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Polysaccharides are widely used in oral drug delivery systems because of the sim-
plicity to obtain the desired drug delivery system and drug release profile, by the con-
trol of cross-linking, insolubility of crosslinked beads in gastric environment and broad
regulatory acceptance. They include sodium alginate, pectin, chitosan, xantan gum, guar
gum, starch, dextran, gellan (1–5). Among their various applications, polysaccharides
are used for oral controlled release matrices, floating or bioadhesive sustained release
beads or tablets, enteric coating, colon targeting of drugs and for pulsatile drug release
(6–9). Pectin is an important ionic polysaccharide found in the plant cell wall, chemically
made up of linear chains of partially methylated galacturonic acid units with an overall
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The purpose of this study was to improve the entrap-
ment efficiency of the water-soluble drug metronidazole
using internal cross-linking agents. Calcium pectinate
beads containing metronidazole were prepared by drop-
ping a drug-pectin solution in 1% and 5% (m/V) calcium
chloride for surface cross-linked beads. For the core
cross-linked beads calcium carbonate was dispersed in
the drug-pectin solution. The beads were characterized
by particle size, swelling ratio, SEM, DSC, and in vitro
drug release. It was found that the beads obtained by co-
re cross-linking produced more drug entrapped beads
than the surface cross-linked beads. Beads obtained using
1% (m/V) calcium chloride showed more drug entrap-
ment than these obtained using 5% calcium chloride.
The core cross-linking of pectin beads reduced drug loss
by about 10–20%. The water lodging capacity of beads
depended upon gel strength which is a function of the
internal gelling agent and pectin concentration. Comple-
te drug release was observed within 30–60 min in the
acidic dissolution medium. This work has showed that
the core cross-linking agent increases the water-soluble
drug entrapment in calcium pectinate beads.
Keywords: ionotropic gelling, core cross-linking agent,
CaCO3, entrapment, metronidazole, Ca-pectinate beads
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molecular mass of 20,000 to 400,000. Calcium ions are essential for gelation of low
methoxyl pectin, which is determined by the degree of esterification and the degree of
amidation. Degrees of esterification and amidation determine the gelling behavior of
pectin. Degrees of esterification, amidation and exact arrangement of acid and methyl
ester groups along the pectin molecule control how the pectin behaves as a gelling
agent. The extent and rate of cross-linking depend on the valency of cross-linking agent,
molecular size of the drug and concentration of the cross-linking agent as well as on the
speed and curing time during processing (10–12). Solubility, molecular size and ionic na-
ture of the drug determine the drug entrapment and drug release. The water soluble and
low molecular mass drugs have poor entrapment compared to insoluble and large mole-
cular mass drugs (13–15).
The drug entrapment and drug release may be governed by the extent of surface
and core cross-linking of beads, as a function of cation penetration into the bead, mole-
cular size of the drug and valency of the cross-linking agent. Beads formed with closely
packed polymer arrangement and egg-box or three-dimensional bonding may have dif-
ferent drug holding and releasing abilities. Low methoxyl-pectins (< 40% esterified) gel
by calcium di-cation bridging between adjacent two-fold helical chains forming the so-
called egg-box junction zone structures as long as a minimum of 14–20 residues can coop-
erate. Inclusion of the internal cross-linking agent may be effective for structuring bead
core and thus enhancing the entrapment efficiency of the water-soluble drug (16, 17).
The purpose of the present work was to study the effect of core cross-linking and
surface cross-linking of pectin beads on the entrapment efficiency of metronidazole,
beads swelling and drug release. CaCO3 and CaCl2 solutions were used as core and sur-
face cross-linking agent, respectively. Metronidazole (MZ), a low molecular mass, water-
-soluble drug, widely used as an anti-amoebic, anti-protozoal and for prevention of re-
currence of peptic ulcer disease caused by H. pylori, was selected as the model drug.
EXPERIMENTAL
Materials
Pectin (LM-104 AS) was a generous gift from CPKelco Pvt. Ltd. (India). Metronida-
zole was donated by Aarti drugs Ltd. (India). Calcium chloride was purchased from Sis-
co Research Lab. Pvt. Ltd. (India). All other chemicals used were of analytical reagent
grade.
Procedures
Preparation of core and surface cross-linked beads – Pectin solutions of different concen-
trations were prepared by dissolving low methoxyl (LM) pectin in water under gentle
agitation (Table I). Metronidazole (400 mg) was dispersed in 10 mL of the pectin solution
under constant stirring for 2 min for uniform distribution. The resultant dispersion was
extruded dropwise through a 1.2-mm diameter needle into 60 mL of stirred calcium
chloride solution of 1% and 5% (m/V) at room temperature. The extrusion flow rate was
approximately 4 mL min–1, and then the beads formed were allowed to remain in the
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stirred solution for 10 min curing time. The beads were filtered and washed with 20 mL
of distilled water, the absence of free metronidazole was observed in higher pectin con-
centration beads dried at room temperature for 24 hours. Such beads are named surface
cross-linked beads.
Surface cross-linked beads containing an internally dispersed cross-linking agent
were prepared by dispersing 400 mg of metronidazole and 10 mg of calcium carbonate
in pectin solutions. The remaining process was as described for surface cross-linked
beads. Though such beads have surface as well as internal cross-linking, for convenience
they are termed core cross-linked beads. The beads prepared by the same procedure
without drug are named placebo beads.
Particle size estimation
The mean diameter of beads was determined using a stereomicroscope (Carl Zeiss,
Germany) attached to a digital camera (Watec, Wat-202, Japan). The captured images
were analyzed using the Biovis Image Plus software (Expert Tech Vision, India). About
20 particles of each batch were analyzed and the average diameter and different surface
factors, such as circulatory factor, elongation, roundness and perimeter ratio, were deter-
mined.
Encapsulation efficiency estimation
The ratio of the actual metronidazole content in the drug-loaded beads to the theo-
retical metronidazole content was termed encapsulation efficiency. The total mass of
dried beads obtained from a batch was considered as practical yield of the process.
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Encapsulation efficiency (%)a EEdiff
(%)1% CaCl2 5% CaCl2
AG3 3 0 38.4 ± 1.2 39.5 ± 1.1 1.1
AG3 (I) 3 0.1 62.5 ± 1.1 59.6 ± 1.2 2.9
AG5 5 0 70.4 ± 2.1 55.0 ± 1.0 15.4
AG5 (I) 5 0.1 86.1 ± 1.5 74.3 ± 3.1 11.8
AG6 6 0 75.7 ± 1.9 56.2 ± 3.3 19.5
AG6 (I) 6 0.1 89.3 ± 2.4 88.0 ± 2.7 1.2
AG7 7 0 79.4 ± 1.7 64.9 ± 2.2 14.5
AG7 (I) 7 0.1 90.8 ± 1.6 89.2 ± 2.3 1.6
AG8 8 0 88.2 ± 1.5 67.0 ± 1.9 21.2
AG8 (I) 8 0.5 93.9 ± 1.0 92.4 ± 0.1 1.5
EEdiff: Encapsulation efficiency difference.
a Mean ± SD, n = 3.
Drug-loaded beads (100 mg) were dissolved in phosphate buffer pH 7.4 by shaking on a
rotary shaker (Steelmet Industries, India) at 200 rpm overnight. The solution was filtered
through a 0.45 mm pore size filter and, after sufficient dilution with phosphate buffer
(pH 7.4), analyzed spectrophotometrically at 320 nm (Jasco V500, Japan). Determina-
tions were made in triplicate.
Surface topography
The beads were mounted on standard specimen mounting stubs and coated with a
thin gold-palladium layer (20 nm) in a sputter coater unit (VG Microtech, UK). Micro-
photographs of the beads were observed at 50´ and 200´ magnification using a Cam-
bridge Stereoscan 120 scanning electron microscope (UK) operated at an acceleration
voltage of 10 kV.
Differential scanning calorimetry (DSC)
Thermograms of metronidazole, calcium pectinate beads without drug and drug-
-loaded beads were obtained using a Mettler-Toledo DSC 821e (Switzerland) instrument
equipped with an intracooler. Indium standard was used to calibrate the DSC tempera-
ture and enthalpy scale. Powder samples were hermetically sealed in perforated alumi-
num pans and heated at a constant rate of 10 °C min–1 over a temperature range of 25–
300 °C. The system was purged with nitrogen gas at the rate of 100 mL min–1 to main-
tain inert atmosphere.
Swelling study
Swelling of the beads was studied in triplicate using three randomly selected beads
from each batch. Beads of known mass were placed in the wire basket of a USP 26 type
II dissolution apparatus (Electrolab TDT-06P, India) containing 900 mL of 0.1 mol L–1
HCl (pH 1.2) maintained at 37 °C (18). The beads were periodically removed at predeter-
mined time intervals during the study period of 2 hours, drained on tissue paper and
weighed.
Dissolution studies
The dissolution of drug loaded calcium pectinate beads was studied using the USP
26 (18) type II dissolution test apparatus containing 900 mL of 0.1 mol L–1 HCl (pH 1.2)
maintained at 37 ± 0.5 °C and stirred at 100 rpm. Samples were collected periodically
and replaced with a fresh dissolution medium. After filtration through Whatman filter
paper, metronidazole concentration was determined spectrophotometrically at 320 nm.
All the readings were done in triplicate. Data analysis was done using »PCP Disso
v2.08« software (Poona College of Pharmacy, India).
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RESULTS AND DISCUSSION
Primary batches of drug-loaded pectin beads containing 3% (m/V) pectin produced
satisfactory beads and this was selected as the minimum concentration for further stud-
ies. The 8% (m/V) pectin concentration was taken as the maximum pectin concentration,
above which the solution was too viscous to drop. Aqueous solution of calcium chloride
(1 and 5%) (m/V) was used as the surface cross-linking agent to compare relative calcium
reactivity. Differences were observed in the encapsulation efficiency of thus formed bat-
ches. Encapsulation efficiency was in the range 38.4 ± 1.2 to 88.2 ± 1.5% as shown in Table
I. The encapsulation efficiency of surface cross-linked beads increased with an increase
in the pectin concentration but decreased with increasing the calcium chloride concen-
tration from 1 to 5%. The calculated entrapment efficiency difference (EEdiff) was 14 to
21% except for batch AG3 containing the lowest polymer content. The increase in en-
trapment efficiency with an increase in pectin concentration at constant drug amount
may be attributed to the availability of excess polymer to encapsulate the drug. The re-
duction in entrapment efficiency using 5% calcium chloride solution may be attributed
to the weakening of surface gel strength due to an excess of Ca2+ ions. The calcium con-
centration vs. gel strength curve reaches a point where further increase in calcium con-
centration does not increase the gel strength and this is indicated as calcium saturation.
As calcium concentration continues to increase beyond this point, the gel strength dec-
reases. This is caused by pre-gelation, a rapid reaction between pectin molecules and
calcium ions, resulting in non-homogeneous gel structure (19, 20). The lower value of
EEdiff for the 3% pectin containing batches can be correlated to the smaller amount of
polymer and higher Ca2+/polymer ratio.
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1% CaCl2 5% CaCl
10 min 30 min 60 min 10 min 30 min 60 min
AG3 CaCl2 49.9 ± 4.2 75.5 ± 4.6 91.9 ± 1.5 53.5 ± 4.5 82.7 ± 4.6 92.0 ± 2.5
AG3 (I) CaCO3 45.5 ± 3.3 67.1 ± 3.2 75.4 ± 2.5 42.9 ± 4.2 67 ± 4.25 83.6 ± 3.5
AG5 CaCl2 61.4 ± 7.2 81.7 ± 8.1 86.2 ± 3.5 38.5 ± 2.5 80.0 ± 8.2 92.4 ± 4.5
AG5 (I) CaCO3 48.4 ± 2.2 68.6 ± 1.8 73.9 ± 4.2 21.9 ± 3.6 60.5 ± 4.2 73.9 ± 3.2
AG6 CaCl2 50.3 ± 2.5 73.6 ± 4.3 79.2 ± 6.2 44.1 ± 2.5 89.0 ± 4.2 96.6 ± 4.5
AG6 (I) CaCO3 21.5 ± 5.2 54.0 ± 2.6 65.3 ± 4.5 63.2 ± 4.2 72.5 ± 3.5 77.2 ± 6.2
AG7 CaCl2 53.0 ± 7.6 78.2 ± 3.5 81.2 ± 3.3 35.9 ± 4.5 87.0 ± 2.5 93.3 ± 3.5
AG7 (I) CaCO3 38.2 ± 5.1 56.5 ± 4.6 68.1 ± 2.4 43.7 ± 6.2 63.7 ± 1.2 68.5 ± 4.2
AG8 CaCl2 65.3 ± 3.5 82.8 ± 5.3 85.6 ± 4.5 42.3 ± 4.2 83.5 ± 2.6 88.0 ± 4.2
AG8 (I) CaCO3 33.3 ± 2.8 60.7 ± 4.3 68.9 ± 4.3 36.9 ± 3 60.1 ± 3.5 67.1 ± 4.2
a Mean ± SD, n = 3.
The entrapment efficiency was further increased in batches containing calcium car-
bonate as the core/internal gelling agent. In the internally gelled batches containing 3%
(m/V) pectin, there was an almost 24 and 20% increase in entrapment efficiency using 1
and 5% (m/V) calcium chloride, respectively. Internally gelled batches containing higher
pectin concentrations, when compared to only surface cross-linked beads using 1% cal-
cium chloride, showed improvement in drug entrapment in the range of 5 to 16% which
reduced with decreasing pectin concentration. In the batches prepared using 5% calcium
chloride, drug loss was markedly reduced by inclusion of the internal cross-linking
agent (Table I).
This phenomenon may be a result of the physical and chemical interactions that can
take place during the pectin gel bead formation. Pectin beads are formed by intermole-
cular cross-linking between divalent calcium ions and the negatively charged carboxyl
group of pectin molecules. Divalent metals establish direct polyanion-cation-polyanion
interaction between pairs of carboxylic groups on the neighboring helices producing an
egg-box model. Weak and flexible gel turns strong and rigid as the cation availability in-
creases with maximum gel strength for utilization of all possible cross-linking sites.
When an excess of divalent cations is present, they compete for interaction with anionic
sites, imposing repulsive forces resulting in weakening of gels (19). In surface cross-lin-
ked beads, the extent of Ca2+ interaction at the surface restricts further entry to the core,
which is compensated by using an internal cross-linking agent, thereby increasing the
bead strength and giving rise to increased dissolution/leaching of small and low mole-
cular mass drug through the cross-linked network. This is supported by the high values
of EEdiff, which can be attributed to the formation of soft gel due to the presence of ex-
cessive calcium ions.
The increase in drug entrapment and reduced values of EEdiff in internally gelled
batches showed the dominance of internal cross-linking over the surface cross-linking.
Intermolecular cohesion, which occurred during core cross-linking, might have counter-
acted the gel weakening, making both the core and surface closely compact. This is sup-
ported by reduced drug loss obtained with the 5% (m/V) cross-linking solution. Keeping
CaCl2 concentration constant, the increase in pectin concentration increased entrapment
efficiency. This may be attributed to the corresponding increase in gel strength.
SEM photographs shown in Fig. 1 explain the surface morphology of dried metron-
idazole loaded Ca-pectinate beads. Beads prepared with 3% pectin solution with 1% cal-
cium chloride showed prominent thin ridges by »pull-away« effect producing a rough
surface, but beads prepared with the same pectin concentration using 5% CaCl2 solution
were deformed with cavities on the surface (Figs. 1a, b). As compared to externally cross-
-linked beads, beads that were internally cross-linked with calcium carbonate and obtai-
ned by using 1 and 5% calcium chloride were spherical with entrapped drug crystals in
thick gel (Figs. 1c, d). Figs. 1e and 1f show that the surface of beads containing the high-
est pectin concentration, with surface and core cross-linking, was comparatively smooth
with both 1% and 5% (m/V) calcium chloride solution in a low resolution of SEM. In
high resolution, fine drug crystals appeared on the surface due to squeezing of the drug
(as in Fig. 1g). The surface of the beads containing the core cross-linking agent showed
fewer drug crystals (Fig. 1h) than beads obtained only by surface cross-linking this re-
confirms that the reduced leaching of drug into the CaCl2 solution may be the reason for
the increased encapsulation efficiency.
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The mean particle size of the beads ranged between 2.073 ± 0.057 and 4.376 ± 0.075
mm. The beads obtained were also evaluated for the circulatory factor and roundness.
The beads were spherical with the circulatory factor in the range of 1.2 to 2.0 and round-
ness in the range of 0.35 to 0.83. In surface cross-linked batches, the mean particle size of
the beads containing a constant drug amount increased with the increase in polymer
concentration. Increase in the calcium ion concentration decreased the gel strength of the
beads; 5% calcium chloride increased bead size.
DSC thermograms of metronidazole, unloaded beads and drug loaded calcium pec-
tinate beads of batch AG5 are shown in Fig. 2. Metronidazole showed melting endo-
therms at 160.79 °C (160.44–167.89 °C). Empty pectin beads had two melting endo-
therms and drug loaded beads had three endotherms because the drug showed its own
characteristic peak. The broad endotherm at 90–115 °C in plain and drug loaded beads
81
A. P. Pawar et al.: Effect of core and surface cross-linking on the entrapment of metronidazole in pectin beads, Acta Pharm. 58 (2008)
75–85.
Fig. 1. Scanning electron micros-
copy of metronidazole-loaded
calcium pectinate at different
magnifications: a) AG 3-1 (24x),
b) AG 3-5 (24x), c) AG 3-1 (I) (24x),
d) AG 3-5 (I) (24x), e) AG 8-1
(24x), f) AG 8-1(I) (24x), g) AG
8-1 (180x), h) AG8-1 (I) (180x).
may be due to water loss, the peak intensity of which decreases in internally cross-lin-
ked beads. Shifts of the drug melting endotherm to higher temperature were observed
in internally cross-linked beads, which may be attributed to slower heat transfer with in-
crease in bead hardness.
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Fig. 2. DSC thermograms of: a) metroni-
dazole, b) empty Ca-pectinate beads, c)
drug-loaded externally cross-linked beads,


















































Fig. 3. Swelling ratio of Ca-
-pectinate beads: a) batch
AG3; b) batch AG5 (mean ±
SD, n = 3).
Internally cross-linked beads of AG3 (Fig. 3a) showed rapid swelling with the short-
est steady state. This may be attributed to faster penetration of the fluid and erosion due
to weak gel strength (Fig. 3b shows the batches containing a low pectin concentration).
Maximum swelling was observed within 20 min. Swelling properties of the beads con-
taining 5% pectin (AG5), high swelling ratio and slower erosion, indicated the optimum
amount of pectin and Ca2+ concentration for cross-linking. The beads prepared with all
concentrations of pectin solution showed a somewhat similar swelling profile with the
swelling ratio around 2 and no erosion within 120 min. The beads obtained by internal
cross-linking had a lower swelling capacity. A lower pectin concentration shows a hig-
her swelling ratio, and vice versa.
All the beads showed almost 80% drug released within 30 to 60 min at pH 1.2. The
drug release was dependent on drug solubility in dissolution medium, because the fluid
migrates into the beads to dissolve the drug and create pores and channels. Fluid ingress
promotes the extent and the rate of beads swelling, creating a large surface area, which
in turn enhances the release of incorporated drugs. A typical drug release profile is
shown in Fig. 4 and the cumulative release at different times is given in Table II. The ini-
tial drug release from beads prepared using 5% calcium chloride solution was slower
than from that prepared using 1% calcium chloride. The delay in drug dissolution re-
veals that the internally cross-linked beads compact the core, which decreases the drug
release from the core of the beads. Internal gelling increased gel strength by cross-linking
in the core, increasing the drug holding capacity.
CONCLUSIONS
The pharmaceutical properties of the ionically cross-linked polysaccharide beads
are not only determined by the concentration and valency of the cation but also by the
uniform internal and external cross-linking. This study emphasized the use of internal
cross-linking agents to obtain cross-linked calcium-pectinate beads, promising for im-
proved drug entrapment, size and shape. This approach may be useful to achieve sustai-
ned release of water-soluble drugs. Further studies should be done using internal cross-
-linking agents of different valency and cross-linking capacity.
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Fig. 4. Effect of internal and ex-
ternal cross-linking on the drug
release profile of batch AG-5
with 1% and 5% CaCl2 as the
external cross-linking agent AG5
(mean ± SD, n = 3).
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S A @ E T A K
Utjecaj umre`avanja na udio metronidazola u pektinskim zrncima
ATMARAM P. PAWAR, ANIL R. GADHE, PRABAKARAN VENKATACHALAM, PRAVEEN SHER
i KAKASAHEB R. MAHADIK
Svrha istra`ivanja bila je pobolj{ati udio vodotopljive ljekovite tvari metronidazola
u pripravcima s pektinskim zrncima koriste}i sredstva za umre`avnje poput kalcijevog
karbonata. Povr{inski umre`ena zrnca kalcijevog pektinata s metronidazolom priprav-
ljena su dokapavanjem otopine lijeka i pektina u 1 i 5% (m/V) otopinu kalcijevog klorida.
Zrnca s umre`enom jezgrom pripravljena su dispergiranjem kalcijevog karbonata u oto-
pinu ljekovite tvari i pektina. Zrncima su odre|eni sljede}i parametri: veli~ina ~estica,
sposobnost bubrenja, SEM, DSC i osloba|anje ljekovite tvari in vitro. Zrnca dobivena
umre`avanjem jezgre sadr`avala su ve}i udio lijeka (10-20%) od povr{inski umre`enih
zrnaca. Zrnca dobivena s 1% (m/V) otopinom kalcijevog klorida sadr`avala su ve}i udio
lijeka od onih dobivenih s 5% otopinom. Kapacitet vezanja vode zrnaca ovisio je o ja-
kosti gela, a jakost gela ovisila je internom agensu za geliranje i koncentraciji pektina. U
kiselom mediju ljekovita tvar se u potpunosti oslobodila unutar 30–60 minuta.
Klju~ne rije~i: ionotropsko geliranje, sredstvo za umre`avanje jezgre, kalcijev karbonat, udio lijeka,
metronidazol, zrnca Ca-pektinata
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Erandwane, Pune-411038, Maharashtra State India
85
A. P. Pawar et al.: Effect of core and surface cross-linking on the entrapment of metronidazole in pectin beads, Acta Pharm. 58 (2008)
75–85.
